Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07365319 |
| Title | A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. (TeLuRide-008) |
| Acronym | TeLuRide-008 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Eikon Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| NYU Langone Hospital Long Island | RECRUITING | Mineola | New York | 11501 | United States | Details |
| NYU Langone Hospital Manhattan | RECRUITING | New York | New York | 10016 | United States | Details |
| White Plains Hospital | RECRUITING | White Plains | New York | 10601 | United States | Details |